Home › Calculator › TRSBF Dividend Calculator 2026
TRSBF DRIP Calculator & Dividend Yield 2026
1.85% YieldHealthcare3SBio Inc. · OTC
Price: $1.73 · Annual div: $0.0319/share · Frequency: annual · Payout ratio: 1% · Ex-div: 2026-07-21
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
TRSBF Dividend Yield
TRSBF (3SBio Inc.) has a dividend yield of 1.85%, based on an annual dividend of $0.0319 per share and a price of $1.73. Over the last 12 months it paid $0.0319 per share — a trailing yield of 1.85%. Dividends are paid annual.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When TRSBF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
TRSBF Dividend History — Last 6 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-07-21Latest | 2026-08-04 | $0.0319 | 1.48% | $2.15 |
| 2025-07-21 | 2025-08-15 | $0.0318 | 1.96% | $3.25 |
| 2024-07-22 | 2024-08-05 | $0.0320 | 4.17% | $0.77 |
| 2023-06-27 | 2023-07-11 | $0.0128 | 1.60% | $0.80 |
| 2022-06-27 | 2022-07-11 | $0.0255 | 3.18% | $0.80 |
| 2018-06-29 | 2018-07-30 | $0.0087 | — | — |
About 3SBio Inc. (TRSBF) — Dividend Analysis 2026
3SBio Inc. is a China-based investment holding company deeply engaged in the biopharmaceutical sector, encompassing the entire value chain from research and development to manufacturing, marketing, and sales of its innovative products. The company's extensive biopharmaceutical portfolio caters to a wide array of therapeutic needs. This includes treatments for various blood disorders like TPIAO (for chemotherapy-induced or immune thrombocytopenia), EPIAO and SEPO (recombinant erythropoietins for anemia), and SPARIN (a low-molecular-weight heparin for deep vein thrombosis prophylaxis and treatment, as well as for preventing clotting during hemodialysis), alongside Aiyishu for iron-deficiency anemia. Its autoimmune and inflammatory disease offerings feature YISAIPU, a tumor necrosis factor inhibitor effective against rheumatoid arthritis, ankylosing spondylitis, and psoriasis. In the oncology domain, 3SBio provides Cipterbin for HER2-positive metastatic breast cancer (in combination with chemotherapy), Intefen (a recombinant human interferon for lymphatic/hematopoietic malignancies and viral infections), and Inleusin (human interleukin-2 for renal cell carcinoma, melanoma, and thoracic fluid accumulation). Other specialized products address conditions such as male alopecia and alopecia areata (Mandi), acute rejection post-renal transplant (Xenopax), glycemic control in type 2 diabetes (Byetta), and diabetic retinopathy (Qiming Keli). In addition to its pharmaceutical operations, 3SBio diversifies its activities through services encompassing trading, project management, consulting, technology, and agriculture. The company has forged strategic collaboration agreements with a multitude of international partners, including prominent names like AstraZeneca, Lilly, Toray Industries Inc, Samsung Bioepis, Refuge Biotechnologies, Verseau, TLC, Numab, GenSight, Sensorion, and the Dana-Farber Cancer Institute. Established in 1993, the company maintains its headquarters in Shenyang, China.
Similar dividend stocks to TRSBF
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full TRSBF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TRSBF position with:
🌍 TRSBF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold TRSBF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.85% | -0.95% | $185 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.57% | -1.23% | $157 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.48% | -1.32% | $148 / yr |
| 🇬🇧 UK ISA | 0% | 1.85% | -0.95% | $185 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.69% | -1.11% | $169 / yr |
| 🇨🇦 TFSA | 0% | 1.85% | -0.95% | $185 / yr |
| 🇨🇦 CA Taxable | 25% | 1.39% | -1.41% | $139 / yr |
| 🇦🇺 Super (pension) | 15% | 1.57% | -1.23% | $157 / yr |
| 🇦🇺 AU Taxable | 30% | 1.29% | -1.50% | $130 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.36% | -1.44% | $136 / yr |
| 🇫🇷 FR Taxable | 30% | 1.29% | -1.50% | $130 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 TRSBF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.03/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 TRSBF Dividend Payment Schedule
TRSBF pays annually — 1 payment per year.
📊 TRSBF vs Healthcare Benchmarks
How TRSBF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TRSBF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ TRSBF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TRSBF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
3SBio Inc. (TRSBF) is currently trading at $1.73, trading near its 52-week low. The current dividend yield is 1.85% based on an annual payout of $0.0319 per share.
TRSBF (3SBio Inc.) — 1.85% Dividend Yield Analysis
3SBio Inc. (TRSBF) is a healthcare stock currently trading at $1.73 with a dividend yield of 1.85%. It pays an annual dividend of $0.0319 per share. The payout ratio of 1% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest TRSBF News
LiveHow investors use the TRSBF dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.